501 related articles for article (PubMed ID: 26590504)
1. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children.
Bradford NK; Edwards RM; Chan RJ
Cochrane Database Syst Rev; 2015 Nov; (11):CD010996. PubMed ID: 26590504
[TBL] [Abstract][Full Text] [Related]
2. Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.
Bradford NK; Edwards RM; Chan RJ
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010996. PubMed ID: 32352563
[TBL] [Abstract][Full Text] [Related]
3. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children: A systematic review.
Bradford NK; Edwards RM; Chan RJ
Int J Nurs Stud; 2016 Jul; 59():51-9. PubMed ID: 27222450
[TBL] [Abstract][Full Text] [Related]
4. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults.
López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Marti S; Carbonell Sanchis R; Burls A
Cochrane Database Syst Rev; 2014 Oct; (10):CD008462. PubMed ID: 25300172
[TBL] [Abstract][Full Text] [Related]
5. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.
López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Martí S; Carbonell Sanchis R; Burls A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD008462. PubMed ID: 30058070
[TBL] [Abstract][Full Text] [Related]
6. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.
López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Martí S; Carbonell Sanchis R
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008462. PubMed ID: 35849083
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.
van den Bosch CH; van Woensel J; van de Wetering MD
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003295. PubMed ID: 34617602
[TBL] [Abstract][Full Text] [Related]
9. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancer.
Arora RS; Roberts R; Eden TO; Pizer B
Cochrane Database Syst Rev; 2010 Dec; (12):CD007785. PubMed ID: 21154387
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.
van de Wetering MD; van Woensel JB; Lawrie TA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD003295. PubMed ID: 24277633
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children.
Brandão LR; Shah N; Shah PS
Cochrane Database Syst Rev; 2014 Mar; (3):CD005982. PubMed ID: 24615288
[TBL] [Abstract][Full Text] [Related]
13. Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis.
Zhong L; Wang HL; Xu B; Yuan Y; Wang X; Zhang YY; Ji L; Pan ZM; Hu ZS
Crit Care; 2017 Jan; 21(1):5. PubMed ID: 28063456
[TBL] [Abstract][Full Text] [Related]
14. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007878. PubMed ID: 26982376
[TBL] [Abstract][Full Text] [Related]
15. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
Shah P; Shah V
Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
[TBL] [Abstract][Full Text] [Related]
16. Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
Shah PS; Shah N
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005983. PubMed ID: 24569952
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants.
McMullan RL; Gordon A
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012181. PubMed ID: 29512818
[TBL] [Abstract][Full Text] [Related]
18. Dressings and securement devices for central venous catheters (CVC).
Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010367. PubMed ID: 26358142
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer.
Schoot RA; van Dalen EC; van Ommen CH; van de Wetering MD
Cochrane Database Syst Rev; 2013 Jun; (6):CD008975. PubMed ID: 23799867
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Heparin and Saline for Prevention of Central Venous Catheter Occlusion in Pediatric Oncology: A Systematic Review and Meta-Analysis.
Semerci R; Bingöl H; Bay Büyükkapu S; Kudubes AA; Bektaş M; Kebudi R
Semin Oncol Nurs; 2023 Aug; 39(4):151426. PubMed ID: 37147152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
